Business

Advertisement

 

Import duty waiver for PPE, masks, raw materials extended to Sept 30

Staff Correspondent | Published: 22:47, Jul 02,2020

 
 

The National Board of Revenue has waived the duty on import of 17 types of products that include personal protective equipments, disinfectants, masks and raw materials of products required to fight the coronavirus outbreak till September 30.

The NBR’s customs wing on Tuesday issued a statutory regulatory order extending the duty exemption for the products as the previous exemption expired on June 30.

According to the SRO, only industrial IRC holder pharmaceutical industry, medical instrument manufacturers and garment manufacturers will be allowed to import the raw materials to produce PPEs, disinfectants and masks following the approval of the Director General of Drug Administration.

There will be no customs duty, regulatory duty, supplementary duty, value-added tax, advance tax and advance income tax on import of the products both for commercial importers and manufacturers.

The products include COVID-19 test kits based on immunological reactions, disinfectants in bulk, COVID-19 test kits based on polymerase chain reaction (PCR) nucleic acid tests, protective garments made from plastic sheeting, plastic face shields,  N95 masks, KN95 masks, protective spectacles and goggles, other breathing appliances and gas masks and COVID-19 diagnostic test instruments and apparatuses.

The raw materials include isopropyl alcohol, felt of textile materials, different types of non-woven man-made filaments and other fabrics impregnated with polyvinyl chloride, ear band for masks and nose protector clip masks.

According to the SRO, the DGDA will regularly determine the quantity of items to be imported by the importers and regularly monitor the quality of imported goods.

The DGDA will also submit a report containing data about the quantity of products imported under the benefit and names of the importers after the deadline of the SRO expires, it said.

Want stories like this in your inbox?

Sign up to exclusive daily email

Advertisement

 

Advertisement

images